article thumbnail

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Cannabis Law Report

Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

article thumbnail

Euro & UK Roundup: Czech Republic, Ireland, San Marino, UK

Cannabis Law Report

A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain. Calls for the medical cannabis programme to be extended. Agriculture worldwide is a major contributor to greenhouse-gas emissions.